September 22 to 25, 2010

Palais des Congrès/Montréal Convention Centre, Canada

Invited Speakers:
Plenaries, Symposia, Workshops

 

The 6th International Congress of Pathophysiology and the 14th International SHR Symposium will feature an exciting program of plenary sessions and a diverse array of parallel sessions and other opportunities to participate in emerging discussions. More information on plenaries will appear on this site as the program evolves.

 

Confirmed Speakers

Keynote Speakers

• Chantal AUTEXIER, Jewish General Hospital, Montréal CANADA
  Pathophysiological pathways: Ageing
• Albert BARABASI, Northeastern University, Boston USA
  Diseasome
• Giuseppe BIANCHI, Department of Science and Biomedical Technology State
  University of Milan, Milan ITALY
  Genome technologies and use of rat networks to understand human diseases
• Benoit COULOMBE, Institut de Recherches Cliniques de Montréal, Montreal
  CANADA
  Novel pathophysiological approaches and tools: From genes to Systems biology and signal transduction
• Allen W. COWLEY, Medical College of Wisconsin, Milwaukee USA
  Novel pathophysiological approaches and tools: From genes to Systems biology and signal transduction
• Alan DENG, Centre de recherche du CHUM Université de Montréal, Montréal CANADA
  Genome technologies and use of rat networks to understand human diseases
• Victor DZAU, Duke Medicine, Durham USA
  Regenerative Medicine of cardiovascular diseases
• Noboru FUKUDA, Nihon University School of Medecine, Tokyo JAPAN
  New approach to BP management
• Aron M. GEURTS, Medical College of Wisconsin, Milwaukee USA
  Novel animal models and genetic modification techniques in the rat
• Vincent GIGUÈRE, McGill Faculty of Medicine, Montréal CANADA
  Novel pathophysiological approaches and tools: ‘Omics’ tools including genomics, trancriptomics, proteomics and pharmacogenomics
• Richard E. GILBERT, University of Toronto, Toronto CANADA
  Novel Diabetic Therapeutic pathways
• Norbert HÜBNER, Max Delbrück Center for Molecular Medicine Berlin, Berlin GERMANY
  Genetics and metabonomics of cardiometabolic diseases
• Hiroshi ITOH, Keio University School of Medicine, Tokyo JAPAN
  Aldosterone and Hypertension
• Norihiro KATO, National Center for Global Health and Medicine, Tokyo JAPAN
  Genetics and metabonomics of cardiometabolic diseases
• Shokei KIM-MITSUYAMA, Kumamoto University Graduate School of Medical Sciences, Kumamoto JAPAN
  Aldosterone and Hypertension
• Jaroslav KUNES, Institute of Experimental Medicine Prague, Prague CZECH REPUBLIC
  Novel pathophysiological approaches and tools: Gene-environment interactions including genomics, epigenomics and environmental exposure
• Theodore KURTZ, University of California, San Francisco USA
  International Okamoto Awards Lectures
• Bernard LEVY, Institut National de la santé et de la recherche médicale, Paris FRANCE
  Regenerative Medicine of cardiovascular diseases
• Peter LIBBY, Brigham and Women's Hospital, Boston USA
  International Okamoto Awards Lectures
• Peter LIU, Toronto General Hospital, Toronto CANADA
  Therapeutic targets
  New approach to BP management
• Tak W. MAK, Princess Margaret Hospital, Toronto CANADA
  Pathophysiological pathways: Metabolism and Cancer
• Tomoji MASHIMO, Kyoto University, Kyoto JAPAN
  Novel animal models and genetic modification techniques in the rat
• Bruce MCMANUS, St. Paul’s Hospital, UBC James Hogg Research Center, Vancouver
  CANADA
  Biomarkers and drug targets in diabetes and cardiovascular diseases
• Tarik MÖRÖY, Institut de Recherches Cliniques de Montréal, Montreal CANADA
  Pathophysiological pathways: Inflammation, infection and immune system diseases
• Marju ORHO-MELANDER, Malmö University Hospital, Malmo SWEDEN
  Biomarkers and drug targets in diabetes and cardiovascular diseases
• John MULLINS, Centre for Cardiovascular Science University of Edinburgh, Edinburgh UK
  Genome technologies and use of rat networks to understand human diseases
• Tommy NILSSON, McGill University, Montréal CANADA
  Novel pathophysiological approaches and tools: ‘Omics’ tools including genomics, trancriptomics, proteomics and pharmacogenomics
• Michael POLLAK, McGill Faculty of Medicine, Montréal CANADA
  Pathophysiological pathways: Metabolism and Cancer
• Constantin POLYCHRONAKOS, McGill University, Montréal CANADA
  Biomakers and drug targets in diabetes and cardiovascular diseases
• Michal PRAVENEC, Institute of Physiology Academy of Sciences of the Czech Republic, Prague CZECH REPUBLIC
  Novel animal models and genetic modification techniques in the rat
• Marc PRENTKI, Centre de Recherche du CHUM, Montréal CANADA
  Novel Diabetic Therapeutic pathways
• Allen D. ROSES, Duke University, Durham USA
  Pharmacogenomics in drug discovery
• Guy ROULEAU, Hôpital Ste Justine, Montréal CANADA
  Pathophysiological pathways: Neurodegenerative disease and pain
• Dr. Kazuaki SHIMAMOTO, Sapporo Medical University, Sapporo JAPAN
  New approach to BP management
• Moshe SZYF, McGill University, Montréal CANADA
  Novel pathophysiological approaches and tools: Gene-environment interactions including genomics, epigenomics and environmental exposure
• Miyako TAKAKI, Nara Medical University, Kashihara JAPAN
  Pathophysiological pathways: Gastrointestinal and lung diseases
• Michel TREMBLAY, Goodman Cancer Research Centre, McGill University, Montréal
  Canada TC-PTP function in immune cells and its inhibition for potential therapeutic applications in human diseases.
• Jacques TURGEON, Montréal CANADA
  PHARMACOGENETICS OF CARDIOVASCULAR DRUGS
• Yoram YAGIL, Laboratory for Molecular Medicine & Israel Rat Genome Center Ben-
  Gurion University Ashkelon ISRAEL
  Novel pathophysiological approaches and tools: Gene-environment interactions including genomics, epigenomics and environmental exposure
• Yuxin YIN, Peking University Health Science Center, Beijing CHINA
  Systems Biology
• Barry ZIRKIN, John Hopkins School of Public Health, Baltimore USA
  Pathophysiological pathways: Ageing

---

Workshop Speakers

• O. AIRAKSINEN, Kuopio FINLAND
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• C. ANDERS, Jena GERMANY
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• Alexei BAGROV, Baltimore USA
  Dietary salt, cardiotonic steroids, hypertension and renal disease
• Harold CHAPMAN, San Francisco USA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• Leonid P. CHURILOV, St. Petersburg RUSSIA
  Frontiers in Biomedical Education: Etiopathogenetic Clusters
• Jacob DE BOER, Amsterdam, THE NETHERLANDS
  Impact of environmental exposures on the reproductive system
• Anna Mae DIEHL, Durham USA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• Nickolai DULIN, Chicago USA
  Purinergic signaling in health and disease
• Kevin GAIDO, Washington DC USA
  Impact of environmental exposures on the reproductive system
• Ryszard GRYGORCZYK, Montréal CANADA
  Purinergic signaling in health and disease
• Osmo HÄNNINEN, Kuopio FINLAND
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• John W. HANRAHAN, Montréal CANADA
  Purinergic signaling in health and disease
• B. HESSE, Jena GERMANY
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• Sandra J. HEWETT, Farmington USA
  Dysfunction of glial cells in neuronal pathologies
• Boris HINZ, Toronto CANADA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• Else K. HOFFMANN, Copenhagen DENMARK
  Cell volume regulation
• Andras KAPUS, Toronto CANADA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• Yeesim KHEW-GOODALL, Adelaide AUSTRALIA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• Anita KOUSHIK, Montréal CANADA
  Folate and one-carbon metabolism in colorectal cancer risk
• Zdenko KOVAC, Zagreb CROATIA
  Frontiers in Biomedical Education: Etiopathogenetic Clusters
• Eduardo R. LAZAROWSKI, Chapel Hill USA
  Purinergic signaling in health and disease
• Frans H. LEENEN, Ottawa CANADA
  Dietary salt, cardiotonic steroids, hypertension and renal disease
• Jerry B. LINGREL, Cincinnati USA
  Dietary salt, cardiotonic steroids, hypertension and renal disease
• Alexander MONGIN, Albany USA
  Purinergic signaling in health and disease
  Dysfunction of glial cells in neuronal pathologies
• Yasunobu OKADA, Okazaki JAPAN
  Cell volume regulation
• Sergei N. ORLOV, Montréal CANADA
  Cell volume regulation
• Trevor OWENS, Odense DENMARK
  Dysfunction of glial cells in neuronal pathologies
• Vassilios PAPADOPOULOS, Montréal CANADA
  Impact of environmental exposures on the reproductive system
• Marie-Élise PARENT, Montréal CANADA
  Traffic-related air pollution and prostate cancer in Montreal
• Gail S. PRINS, Chicago, USA
  Impact of environmental exposures on the reproductive system
• Marie-France RAYNAULT, Montréal CANADA
  Impact of environmental exposure on public health
• J. REICHENBACH, Jena GERMANY
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• Marie-Claude ROUSSEAU, Montréal CANADA
  Occupational exposure to lead and cancer risk
• Markus RITTER, Vienna AUSTRIA
  Cell volume regulation
• Serge RIVEST, Québec CANADA
  Dysfunction of glial cells in neuronal pathologies
• Laszlo ROSIVALL, Budapest HUNGARY
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• N. SCHILLING, Jena GERMANY
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• Lyanne C. SCHLICHTER, Toronto CANADA
  Dysfunction of glial cells in neuronal pathologies
• William SCHNAPER, Chicago USA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast
• H. C. SCHOLLE, Jena GERMANY
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• Jean SÉVIGNY, Québec CANADA
  Purinergic signaling in health and disease
• Joseph I. SHAPIRO, Toledo USA
  Dietary salt, cardiotonic steroids, hypertension and renal disease
• Jack SIEMIATYCKI, Montréal CANADA
  A broad overview of recognized environmental and lifestyle causes of cancer
• Vladimir STRBAK, Bratislava SLOVAKIA
  Cell volume regulation
• H. WAGNER, Münster GERMANY
  Pathophysiological Mechanism Relating to Unspecific Back Pain – an Update
• Zi-Jian XIE, Toledo USA
  Dietary salt, cardiotonic steroids, hypertension and renal disease
• Michael ZEISBERG, Boston USA
  Epithelial/Mesenchymal Transition/organ fibrosis and the myofibroblast